NEW YORK (GenomeWeb News) – Response Genetics said this week that it has named Christine Meda as president of the company. Kathleen Danenberg, who held the position previously, will continue to serve as CEO of the company.
Meda was most recently president and CEO of Arcxis Biotechnologies. She also founded and is president of RxDxLink, and has served as president and COO of Diamics. Prior to that, Meda held various positions at Roche Molecular Diagnostics, including vice president of business development and vice president of women's health.
NeoGenomics has appointed Kevin Johnson and Raymond Hipp to join its board of directors. Johnson and Hipp will fill the positions left vacant by the resignations of George O'Leary and Marvin Jaffe.
Johnson is chairman of the board of Aureon Biosciences. He formerly was chairman, CEO, and president of DIANON Systems, and he also worked at Quest Diagnostics and in Corning's Life Sciences Division. Hipp previously was chairman, president, and CEO of Alternative Resources Corporation.
RedPath Integrated Pathology has named Dennis Smith to replace Mark Myslinksi as company CEO effective immediately. Myslinksi recently was appointed SVP and GM, Diagnostics at Hologic. Smith had been in executive management at Ameripath, as chief medical officer, and executive VP of Genomic Strategies, and executive director of that firm's Advanced Diagnostics division.
AB Sciex has appointed Ranier Blair president. Previously he was president for North America & Europe of printer company Videojet. Prior to that, he was president and CEO of construction chemical company MAPEI Americas and was an executive with BASF Group.
Microarrays Inc. has appointed Andrew Jennings as its president of business development. Prior to joining MI, Jennings led the sales organization for Open Biosystems, now part of Thermo Fisher Scientific, for five years.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.